Log In
BCIQ
Print this Print this
 

fasudil hydrochloride hydrate (AT-877)

  Manage Alerts
Collapse Summary General Information
Company Asahi Kasei Pharma Corp.
DescriptionOral fasudil hydrochloride hydrate
Molecular Target Rho kinase
Mechanism of ActionRho kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today